News

Novartis CEO Joseph Jimenez said the investment is strengthening the importance of Stein as Manufacturing Center of Excellence for sterile and solid dosage forms and will play a

The company has also expanded its available list of methyltransferase and related proteins to 27. RBC chief technology officer Haiching Ma said, "The new facility expands our space

The injectable, sustained-release intravitreal insert releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic DME. pSivida president and chief executive

The supplement, New Life Naturals: For Her Senses, is intended to help the American women suffering with female sexual dysfunction (FSD). Nouveau has opted to partner with an

The synthetic vasopressin analogue acts through the vasopressin V1 receptor as a systemic vasoconstrictor, primarily in the splanchnic (abdominal) circulation. Thus effective arterial volume increases and renal blood

The Nagpur facility is intended to export formulations to developed markets like US, Europe, Japan and along with other key emerging markets. The new formulation plant is expected

LE-Poly ICLC is an antiviral agent proven to be effective in animal studies against avian influenza virus, ebola and alphavirus infections. Under a sub-contract from Oncovir, Dalton established

The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. The dashboard utilizes content from Thomson Reuters

Under the agreement, ProMetic will receive $1.4m and the client will be provided with a biosimilar product. PBL chief executive officer Steve Burton said the company’s technology allows